Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 6,790 shares at $15.27 ($104K) on 2023-04-18, disclosed to the SEC on 2023-04-19.
Open-market sale of $104k IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.27 | 3,395 | $52K | 50.0% |
| 2 | $15.27 | 3,395 | $52K | 50.0% |
| Total | $15.27 avg | 6,790 | $104K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $644K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |